ursodeoxycholic acid has been researched along with Kidney Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denk, H; Eggertsen, G; Eller, K; Fickert, P; Halilbasic, E; Jaeschke, H; Krones, E; Langner, C; Moustafa, T; Pollheimer, MJ; Rosenkranz, AR; Silbert, D; Stokman, G; Thueringer, A; Trauner, M; Wagner, CA; Wells, RG; Yang, M | 1 |
Cetin, M; Gökce, M; Kuskonmaz, B; Tuncer, M; Uckan Cetinkaya, D | 1 |
Eller, K; Fickert, P; Frauscher, B; Grahammer, F; Huber, TB; Kirsch, AH; Krones, E; Marschall, HU; Pollheimer, MJ; Racedo, S; Rosenkranz, AR; Ståhlman, M; Trauner, M; Wagner, K; Wahlström, A | 1 |
Adler, G; Reinshagen, M | 1 |
Vasil'ev, AIu | 1 |
1 review(s) available for ursodeoxycholic acid and Kidney Diseases
Article | Year |
---|---|
[Extraintestinal manifestations].
Topics: Amyloidosis; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholelithiasis; Cohort Studies; Controlled Clinical Trials as Topic; Crohn Disease; Cross-Sectional Studies; Drug Therapy, Combination; Eye Diseases; Humans; Immunosuppressive Agents; Joint Diseases; Kidney Calculi; Kidney Diseases; Liver Diseases; Longitudinal Studies; Lung Diseases; Nervous System Diseases; Osteoporosis; Pancreatitis; Placebos; Prospective Studies; Retrospective Studies; Risk; Risk Factors; Skin Diseases; Thromboembolism; Ursodeoxycholic Acid | 2003 |
4 other study(ies) available for ursodeoxycholic acid and Kidney Diseases
Article | Year |
---|---|
Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice.
Topics: Animals; Bile Acids and Salts; Cholestasis; Common Bile Duct; Disease Models, Animal; Kidney Diseases; Kidney Tubules; Ligation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephritis, Interstitial; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2013 |
Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis.
Topics: Administration, Oral; Adolescent; Age Factors; Amphotericin B; Anticoagulants; Antifungal Agents; Busulfan; Child; Child, Preschool; Drug Therapy, Combination; Enoxaparin; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Infant; Kaplan-Meier Estimate; Kidney Diseases; Male; Parenteral Nutrition, Total; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Turkey; Ursodeoxycholic Acid; Vitamin E; Young Adult | 2013 |
NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
Topics: Animals; Bile Acids and Salts; Cholestasis; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Ligation; Lipocalin-2; Male; Mice; Mice, Inbred C57BL; Nephritis, Interstitial; Ursodeoxycholic Acid | 2017 |
[The role of radiation study methods in the expertise of flight personnel with kidney diseases].
Topics: Adult; Aerospace Medicine; Humans; Kidney; Kidney Diseases; Military Personnel; Radioisotope Renography; Russia; Tomography, X-Ray Computed; Ultrasonography; Urinary Bladder; Ursodeoxycholic Acid; Work Capacity Evaluation | 1999 |